Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

FF Lang; C Conrad; C Gomez-Manzano; WKA Yung; R Sawaya; JS Weinberg; SS Prabhu; G Rao; GN Fuller; KD Aldape; J Gumin; LM Vence; I Wistuba; J Rodriguez-Canales; PA Villalobos; Clemens Dirven; S Tejada; RD Valle; M M Alonso; B Ewald; JJ Peterkin; F Tufaro; J Fueyo

doi:10.1200/jco.2017.75.8219

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

FF Lang, C Conrad, C Gomez-Manzano, WKA Yung, R Sawaya, JS Weinberg, SS Prabhu, G Rao, GN Fuller, KD Aldape, J Gumin, LM Vence, I Wistuba, J Rodriguez-Canales, PA Villalobos, Clemens Dirven, S Tejada, RD Valle, M M Alonso, B EwaldJJ Peterkin, F Tufaro, J Fueyo

Neurosurgery

Research output: Contribution to journal › Article › Academic › peer-review

504 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1419-+
Journal	Journal of Clinical Oncology
Volume	36
Issue number	14
DOIs	https://doi.org/10.1200/jco.2017.75.8219
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1200/jco.2017.75.8219

http://hdl.handle.net/1765/111216

Cite this

Lang, FF., Conrad, C., Gomez-Manzano, C., Yung, WKA., Sawaya, R., Weinberg, JS., Prabhu, SS., Rao, G., Fuller, GN., Aldape, KD., Gumin, J., Vence, LM., Wistuba, I., Rodriguez-Canales, J., Villalobos, PA., Dirven, C., Tejada, S., Valle, RD., Alonso, M. M., ... Fueyo, J. (2018). Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. Journal of Clinical Oncology, 36(14), 1419-+. https://doi.org/10.1200/jco.2017.75.8219

@article{2a13b67104264a5f97997a31c269a2dd,

title = "Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma",

author = "FF Lang and C Conrad and C Gomez-Manzano and WKA Yung and R Sawaya and JS Weinberg and SS Prabhu and G Rao and GN Fuller and KD Aldape and J Gumin and LM Vence and I Wistuba and J Rodriguez-Canales and PA Villalobos and Clemens Dirven and S Tejada and RD Valle and Alonso, {M M} and B Ewald and JJ Peterkin and F Tufaro and J Fueyo",

year = "2018",

doi = "10.1200/jco.2017.75.8219",

language = "Undefined/Unknown",

volume = "36",

pages = "1419--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "14",

}

Lang, FF, Conrad, C, Gomez-Manzano, C, Yung, WKA, Sawaya, R, Weinberg, JS, Prabhu, SS, Rao, G, Fuller, GN, Aldape, KD, Gumin, J, Vence, LM, Wistuba, I, Rodriguez-Canales, J, Villalobos, PA, Dirven, C, Tejada, S, Valle, RD, Alonso, MM, Ewald, B, Peterkin, JJ, Tufaro, F & Fueyo, J 2018, 'Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma', Journal of Clinical Oncology, vol. 36, no. 14, pp. 1419-+. https://doi.org/10.1200/jco.2017.75.8219

TY - JOUR

T1 - Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

AU - Lang, FF

AU - Conrad, C

AU - Gomez-Manzano, C

AU - Yung, WKA

AU - Sawaya, R

AU - Weinberg, JS

AU - Prabhu, SS

AU - Rao, G

AU - Fuller, GN

AU - Aldape, KD

AU - Gumin, J

AU - Vence, LM

AU - Wistuba, I

AU - Rodriguez-Canales, J

AU - Villalobos, PA

AU - Dirven, Clemens

AU - Tejada, S

AU - Valle, RD

AU - Alonso, M M

AU - Ewald, B

AU - Peterkin, JJ

AU - Tufaro, F

AU - Fueyo, J

PY - 2018

Y1 - 2018

U2 - 10.1200/jco.2017.75.8219

DO - 10.1200/jco.2017.75.8219

M3 - Article

SN - 0732-183X

VL - 36

SP - 1419-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14

ER -